Cargando...
Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer
Recent developments in massively parallel sequencing and digital genomic techniques support the clinical validity of cell‐free circulating tumour DNA (ctDNA) as a ‘liquid biopsy’ in human cancer. In breast cancer, ctDNA detected in plasma can be used to non‐invasively scan tumour genomes and quantif...
Gardado en:
| Publicado en: | Mol Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528975/ https://ncbi.nlm.nih.gov/pubmed/26776681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.12.001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|